Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating donor stem cell transplantation for high-risk chronic lymphocytic leukemia or small lymphocytic lymphoma has completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2017-05-03